Metabolomics analysis identifies d-Alanine-d-Alanine ligase as the primary lethal target of d-Cycloserine in mycobacteria.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Proteome Research

• Publication date

  2014-02-07

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1021/pr4010579PMID 24303782PMCID PMC3975674
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Kinetic mechanism and inhibition of Mycobacterium tuberculosis d‐alanine:d‐alanine ligase by the antibiotic d‐cycloserine

  2013cited by this paper
• PRIMe Update: Innovative Content for Plant Metabolomics and Integration of Gene Expression and Metabolite Accumulation

  2013cited by this paper
• Alanine racemase mutants of Mycobacterium tuberculosis require D-alanine for growth and are defective for survival in macrophages and mice.

  2012cited by this paper
• Transaminases for the synthesis of enantiopure beta-amino acids

  2012cited by this paper
• HMDB 3.0—The Human Metabolome Database in 2013

  2012cited by this paper
• Structural perspective of peptidoglycan biosynthesis and assembly.

  2012cited by this paper
• Sample preparation of Mycobacterium tuberculosis extracts for nuclear magnetic resonance metabolomic studies.

  2012cited by this paper
• Domain enhanced lookup time accelerated BLAST

  2012cited by this paper
• Regulation of proline metabolism in mycobacteria and its role in carbon metabolism under hypoxia

  2012cited by this paper
• Simultaneous Quantification and Identification of Individual Chemicals in Metabolite Mixtures by Two-Dimensional Extrapolated Time-Zero 1H−13C HSQC (HSQC0)

  2011cited by this paper
• TubercuList--10 years after.

  2011cited by this paper
• Structure of the Mycobacterium tuberculosis d-Alanine:d-Alanine Ligase, a Target of the Antituberculosis Drug d-Cycloserine

  2010cited by this paper
• How antibiotics kill bacteria: from targets to networks

  2010cited by this paper
• A Conserved Gene Cluster Rules Anaerobic Oxidative Degradation of l-Ornithine

  2009cited by this paper
• Impairment of D-alanine biosynthesis in Mycobacterium smegmatis determines decreased intracellular survival in human macrophages.

  2009cited by this paper
• PRIMe: A Web Site That Assembles Tools for Metabolomics and Transcriptomics

  2008cited by this paper
• Comprehensive treatment of extensively drug-resistant tuberculosis.

  2008cited by this paper
• MetaboMiner – semi-automated identification of metabolites from 2D NMR spectra of complex biofluids

  2008cited by this paper
• Metabolite identification via the Madison Metabolomics Consortium Database

  2008cited by this paper
• Peptidoglycan structure and architecture.

  2008cited by this paper
• Synthesis and Biological Aspects of Mycolic Acids: An Important Target Against Mycobacterium tuberculosis

  2008cited by this paper
• SOGGY: solvent-optimized double gradient spectroscopy for water suppression. A comparison with some existing techniques.

  2007cited by this paper
• The MetaCyc Database of metabolic pathways and enzymes and the BioCyc collection of Pathway/Genome Databases

  2007cited by this paper
• The Alanine Racemase of Mycobacterium smegmatis Is Essential for Growth in the Absence of d-Alanine

  2007cited by this paper
• KEGG for linking genomes to life and the environment

  2007cited by this paper
• Use of NMR metabolomics to analyze the targets of D-cycloserine in mycobacteria: role of D-alanine racemase.

  2007cited by this paper
• Ncbi reference sequence (refseq): a curated non - redundant sequence database of genomes

  2005cited by this paper
• The magic bullets and tuberculosis drug targets.

  2005cited by this paper
• Side effects associated with the treatment of multidrug-resistant tuberculosis.

  2005cited by this paper
• The 1.9 A crystal structure of alanine racemase from Mycobacterium tuberculosis contains a conserved entryway into the active site.

  2005cited by this paper
• N Glycolylation of the Nucleotide Precursors of Peptidoglycan Biosynthesis of Mycobacterium spp. Is Altered by Drug Treatment

  2005cited by this paper
• NCBI Reference Sequence (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins

  2004cited by this paper
• Using NMRView to visualize and analyze the NMR spectra of macromolecules.

  2004cited by this paper
• Database resources of the National Center for Biotechnology

  2003cited by this paper
• Roles of Mycobacterium smegmatisd-Alanine:d-Alanine Ligase and d-Alanine Racemase in the Mechanisms of Action of and Resistance to the Peptidoglycan Inhibitor d-Cycloserine

  2003cited by this paper
• Structure and function of the Mur enzymes: development of novel inhibitors

  2002cited by this paper
• Mycobacterium smegmatis d-Alanine Racemase Mutants Are Not Dependent on d-Alanine for Growth

  2002cited by this paper
• Dehydrogenases and Transaminases in Asymmetric Synthesis

  2001cited by this paper
• Dehydrogenases and transaminases in asymmetric synthesis.

  2001cited by this paper
• Biosynthesis of the arabinogalactan-peptidoglycan complex of Mycobacterium tuberculosis.

  2001cited by this paper
• Characterization of the alanine racemases from two mycobacteria.

  2001cited by this paper
• Antibiotic side effects.

  2001cited by this paper
• Novel biosynthetic approaches to the production of unnatural amino acids using transaminases.

  1998cited by this paper
• Pathogenicity and Immunogenicity of aListeria monocytogenes Strain That Requiresd-Alanine for Growth

  1998cited by this paper
• Overexpression of the D-alanine racemase gene confers resistance to D-cycloserine in Mycobacterium smegmatis

  1997cited by this paper
• The ubiquitous cofactor NADH protects against substrate‐induced inhibition of a pyridoxal enzyme

  1996cited by this paper
• NMRPipe: A multidimensional spectral processing system based on UNIX pipes

  1995cited by this paper
• Peptidoglycan biosynthesis in Escherichia coli: variations in the metabolism of alanine and D-alanyl-D-alanine.

  1992cited by this paper
• Stereospecificity of reactions catalyzed by bacterial D-amino acid transaminase.

  1989cited by this paper
• D-cycloserine: a ligand for the N-methyl-D-aspartate coupled glycine receptor has partial agonist characteristics.

  1989cited by this paper
• Mechanism of d-Cycloserine Action: Alanine Racemase from Escherichia coli W

  1972cited by this paper
• Lethal Synthesis of Methylglyoxal by Escherichia coli During Unregulated Glycerol Metabolism

  1971cited by this paper
• Isolation and characterization of uridine diphosphate-N-glycolylmuramyl-L-alanyl-gamma-D-glutamyl-meso-alpha,alpha'-diaminopimelic acid from Mycobacterium tuberculosis.

  1970cited by this paper
• Isolation and characterization of uridine diphosphate-N-glycolylmuramyl-L-alanyl-γ-D-glutamyl-meso-α,α′-diaminopimelic acid from Mycobacterium tuberculosis

  1970cited by this paper
• D-Cycloserine and O-Carbamyl-D-serine

  1967cited by this paper
• ANTAGONISM OF d-CYCLOSERINE INHIBITION OF MYCOBACTERIAL GROWTH BY d-ALANINE

  1963cited by this paper

• L-Cycloserine, not D-Cycloserine, inhibits IscS-mediated iron-sulfur cluster biosynthesis in Escherichia coli.

  2026cites this paper
• The Pyridoxal-5'-Phosphate-Dependent Enzymes of Mycobacterium tuberculosis.

  2026cites this paper
• Contemporary review on Metabolomic applications towards biomarker discovery and tuberculosis diagnosis

  2025cites this paper
• Mechanistic Insights into the Reversible Inhibition of d-Cycloserine in Alanine Racemase from Mycobacterium tuberculosis

  2025cites this paper
• D-alanine synthesis and exogenous alanine affect the antimicrobial susceptibility of Staphylococcus aureus

  2025cites this paper
• Dual transcriptional inhibition of glutamate and alanine racemase is synergistic in Mycobacterium tuberculosis

  2024cites this paper
• Simulated LC-MS Data Set for Assessing the Metabolomics Data Processing Pipeline Implemented into MVAPACK.

  2024cites this paper
• Cytotoxic and Antiproliferative Activity of LASSBio-2208 and the Attempts to Determine Its Drug Metabolism and Pharmacokinetics In Vitro Profile

  2024cites this paper
• Flavonoids: A treasure house of prospective pharmacological potentials

  2024cites this paper
• Amino Acid Profiling as A Screening and Prognostic Biomarker in Active Tuberculosis Patients.

  2023cites this paper
• Revolutionizing Tuberculosis Treatment: Uncovering New Drugs and Breakthrough Inhibitors to Combat Drug-Resistant Mycobacterium tuberculosis.

  2023cites this paper
• Wollamide Cyclic Hexapeptides Synergize with Established and New Tuberculosis Antibiotics in Targeting Mycobacterium tuberculosis

  2023cites this paper
• How do Mutations of Mycobacterium Genes Cause Drug Resistance in Tuberculosis?

  2023cites this paper
• Deciphering the mechanism of action of antitubercular compounds with metabolomics

  2021cites this paper
• Discovery of novel antibacterial agents: Recent developments in D‐alanyl‐D‐alanine ligase inhibitors

  2021cites this paper
• Occurrence and Distribution of Antibiotic Resistance Genes in Municipal Wastewater Treatment Plants with D-Type Filters

  2021cites this paper
• Anti-mycobacterial natural products and mechanisms of action.

  2021cites this paper
• Insights into the Inhibition of Aeromonas hydrophila d-Alanine-d-Alanine Ligase by Integration of Kinetics and Structural Analysis.

  2020cites this paper
• Pharmacomodulations of the benzoyl-thiosemicarbazide scaffold reveal antimicrobial agents targeting d-alanyl-d-alanine ligase in bacterio.

  2020cites this paper
• Genome Subtraction and Comparison for the Identification of Novel Drug Targets against Mycobacterium avium subsp. hominissuis

  2020cites this paper
• Integron gene cassettes harboring novel variants of d-alanine-d-alanine ligase confer high-level resistance to d-cycloserine

  2020cites this paper
• Mycobacterial Cell Wall: A Source of Successful Targets for Old and New Drugs

  2020cites this paper
• d-Cycloserine destruction by alanine racemase and the limit of irreversible inhibition

  2020cites this paper
• Digging Deeper to Save the Old Anti-tuberculosis Target: D-Alanine–D-Alanine Ligase With a Novel Inhibitor, IMB-0283

  2020cites this paper
• c-di-AMP Accumulation Impairs Muropeptide Synthesis in Listeria monocytogenes

  2020cites this paper
• Antibiotics and resistance: the two-sided coin of the mycobacterial cell wall

  2020cites this paper
• Mycobacterium tuberculosis curli pili (MTP) deficiency is associated with alterations in cell wall biogenesis, fatty acid metabolism and amino acid synthesis

  2020cites this paper
• Inhibition of Campylobacter jejuni Biofilm Formation by D-Amino Acids

  2020cites this paper
• Metabolic interventions for the prevention and treatment of daptomycin non-susceptibility in Staphylococcus aureus.

  2019cites this paper
• Deficiency of D‐alanyl‐D‐alanine ligase A attenuated cell division and greatly altered the proteome of Mycobacterium smegmatis

  2019cites this paper
• Assessment of metabolic changes in Mycobacterium smegmatis wild type and alr mutant strains: evidence for a new pathway of D- alanine biosynthesis

  2019cites this paper
• DdlR, an essential transcriptional regulator of peptidoglycan biosynthesis in Clostridioides difficile

  2019cites this paper
• Complex formation between Mur enzymes from Streptococcus pneumoniae.

  2019cites this paper
• The application of metabolomics toward pulmonary tuberculosis research.

  2019cites this paper
• Mining the cellular inventory of pyridoxal phosphate-dependent enzymes with functionalized cofactor mimics

  2018cites this paper
• The Biological Properties and Potential Interacting Proteins of d-Alanyl-d-alanine Ligase A from Mycobacterium tuberculosis

  2018cites this paper
• Validation of Cycloserine Efficacy in Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis in Beijing, China

  2018cites this paper
• Mass spectrometry-based metabolomics for tuberculosis meningitis.

  2018cites this paper
• Overexpression of a newly identified d‐amino acid transaminase in Mycobacterium smegmatis complements glutamate racemase deletion

  2018cites this paper
• The role of the CroR response regulator in resistance of Enterococcus faecalis to D‐cycloserine is defined using an inducible receiver domain

  2018cites this paper
• Drug permeation and metabolism in Mycobacterium tuberculosis: Prioritising local exposure as essential criterion in new TB drug development

  2018cites this paper
• The Involvement of the Mitochondrial Amidoxime Reducing Component (mARC) in the Reductive Metabolism of Hydroxamic Acids

  2018cites this paper
• Biochemical Characterization of the Mycobacterium smegmatis Threonine Deaminase.

  2018cites this paper
• 1-(2-Hydroxybenzoyl)-thiosemicarbazides are promising antimicrobial agents targeting d-alanine-d-alanine ligase in bacterio.

  2018cites this paper
• Addressing critical knowledge gaps to improve and shorten multidrug-resistant tuberculosis treatment regimens in children

  2018cites this paper
• The role of metabolomics in tuberculosis treatment research.

  2017cites this paper
• The Metabolomic Strategy in Tuberculosis Therapy.

  2017cites this paper
• Cell wall: A versatile fountain of drug targets in Mycobacterium tuberculosis.

  2017cites this paper
• Multidimensional NMR approaches towards highly resolved, sensitive and high-throughput quantitative metabolomics.

  2017cites this paper
• Mechanism-Based Inhibition of the Mycobacterium tuberculosis Branched-Chain Aminotransferase by d- and l-Cycloserine.

  2017cites this paper
• Role of Alanine Racemase Mutations in Mycobacterium tuberculosis d-Cycloserine Resistance

  2017cites this paper
• Current therapies for the treatment of multidrug-resistant tuberculosis in children in India

  2017cites this paper
• Emerging Approaches to Tuberculosis Drug Development: At Home in the Metabolome.

  2017cites this paper
• Characterising tuberculosis and treatment failure thereof using metabolomics

  2017cites this paper
• Assessment of Metabolic Changes in Mycobacterium smegmatis Wild-Type and alr Mutant Strains: Evidence of a New Pathway of d-Alanine Biosynthesis.

  2017cites this paper
• Identification of novel mutations associated with cycloserine resistance in Mycobacterium tuberculosis

  2017cites this paper
• Adverse effects of oral second-line antituberculosis drugs in children

  2016cites this paper
• Utility of Novel Plasma Metabolic Markers in the Diagnosis of Pediatric Tuberculosis: A Classification and Regression Tree Analysis Approach.

  2016cites this paper
• Structure of D-alanine-D-alanine ligase from Yersinia pestis: nucleotide phosphate recognition by the serine loop.

  2016cites this paper
• Genetic mechanisms of D-cycloserine resistance.

  2016cites this paper
• New Genomics Tools and Strategies for Studying Antibiotics and Antibiotic-Resistance in Staphylococcus Aureus

  2016cites this paper
• Untargeted Metabolomics To Ascertain Antibiotic Modes of Action

  2016cites this paper
• d-Alanine metabolism is essential for growth and biofilm formation of Streptococcus mutans.

  2016cites this paper
• Neglected diseases prioritized in Brazil under the perspective of metabolomics: A review

  2015cites this paper
• Identification of novel mutations associated with clofazimine resistance in Mycobacterium tuberculosis.

  2015cites this paper
• Mycobacterium tuberculosis metabolism.

  2015cites this paper
• Vrste, filogenetske karakteristike i genetička osnova rezistencije multirezistentnih sojeva Mycobacterium tuberculosis kompleksa izolovanih u Srbiji

  2015cites this paper
• Metabolomics: Applications and Promise in Mycobacterial Disease.

  2015cites this paper
• Generation and screening of a comprehensive Mycobacterium avium subsp. paratuberculosis transposon mutant bank

  2014cites this paper
• A microfluidic platform for quantitative analysis of single mycobacteria cells

  2014cites this paper
• Unified and Isomer-Specific NMR Metabolomics Database for the Accurate Analysis of 13C–1H HSQC Spectra

  2014cites this paper
• Impact of divalent metal cations on the catalysis of peptide bonds: a DFT study

  2014cites this paper
• Quantitative 2D liquid‐state NMR

  2014cites this paper